Cancer Screening Market Driven by Demand for Early Diagnosis by IndustryARC

Cancer Testing Equipment Market By Materials, By Product, By Preparation Method, By Application and By Geography Analysis - Forecast 2019 - 2024 www.industryarc.com

Cancer Testing Equipment Market 2019-2024

sales@industryarc.com

Industry Market Research for Business Leaders, Strategists, Decision Makers

Press Release According to the new market research report by IndustryARC titled “ Cancer Testing and Screening Market By Techniques (Imaging, Biopsy,, Biomarkers); By Cancer Type (Respiratory, Breast, Skin, Digestive),Stage, Gender, Product Type, Geography - Forecasts 2018 – 2023” the market is expected to grow due to the rise in geriatric population and unhealthy lifestyles. Browse 86 Market Tables, 179 Figures spread through 156 slides and an in-depth TOC on “Cancer Testing and Screening Market (2018 - 2023)" https://industryarc.com/Report/15062/cancer-testing-screening-market.html Americas to have a major share in the Cancer Testing and Screening Market : Americas will dominate the Cancer Testing and Screening Market during the forecast period. Asia Pacific will have the highest growth in the market due to increasing number of cancer affected people in the region. In the US, Cancer is the second main cause of deaths. In men, prostrate, lung, and colon accounted for 44% of the diagnosed cancers in 2016. Prostate cancer represents 1 out of 5 cases. In women, three types of cancers in 2016 were breast, lung, and colon. To curb such cancers, continuous screening is needed. This will drive the growth of Cancer screening in US. In Asia Pacific, increasing population and ageing in China has resulted in the increasing incidences and mortality of cancer in the region. This has compelled the government in the region to propose demonstration projects. WHO proposed Program for Cancer prevention and control in China, the program will provide cancer screening facilities. Selected Analysis done in the full Report: Imaging techniques involves the process of creating a visual representation of the interior of a body for clinical analysis with regard to the functioning of the internal organs. This process for diagnosis of cancer includes radiography, computed tomography, magnetic resonance imaging, and endoscopy. Imaging tests such as CT scan and X rays generate pictures of the body’s interior without the need for incision. They provide information about the size, shape, and location of the problem. Endoscopy plays an important role in identifying the spread of cancer in the patient’s body. Various kinds of endoscopy include endoscopic ultrasound, endoscopic retrograde, and cholangiopancreatography (ERCP). Excerpts on Market Growth Factors : Growing demand for enhanced procedure accuracy during cancer testing for avoiding the side effects has driven the need for advanced technologies. This has driven the R&D investments in the Cancer Testing and Screening Market. Testing and screening programs can reduce the burden of cancer by ensuring people get the tests done in a timely manner. Improvements in Low Dose Computed Tomography (LDCT) technology and minimally surgical techniques makes the adoption of lung cancer screening stronger. Unhealthy lifestyles such as lack of physical exercise and consumption of diets rich in fats, sugars, and salts will raise the risk for cancer. This drives the growth of the Cancer Testing and Screening Market. Key players of the Cancer Testing and Screening Market: F. Hoffmann-La Roche Ltd. (Roche Diagnostics), Danaher, Johnson & Johnson, Abbott Diagnostics, Siemens Healthcare and Beckton Dickinson are expected to be the dominant players of the cancer molecular testing market.

Cancer Testing Equipment Market

F.Hoffmann-La Roche provides test service in treating and diagnosing breast cancer. Danaher designs, manufactures, and markets healthcare, environmental, and industrial equipment. Recently, Johnson & Johnson acquired C-SATS, a Seattle startup that gives performance reviews for surgeons. Abbot provides a broad range of medical devices, diagnostics, and nutrition products. Browse Related Reports: Genomics in Cancer Care Market -Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025 https://industryarc.com/Report/16885/genomics-in-cancer-care-market.html

U.S. Drug Testing Market:By Sample Type (Hair, Fingernails, Umbilical Cord, Meconium, Blood, Urine); By Application (Drug Testing Laboratories, Law Enforcement Agencies, Drug Treatment Centers); By Type (Rapid Testing Devices, Equipment, Consumables) â&#x20AC;&#x201C; Forecast (2017-2022) https://industryarc.com/Report/18353/us-drug-testing-market.html

About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare. IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business. We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today. Contact Us: Mr. Venkateshwar Reddy Business Development Manager Email: sales@industryarc.com Contact Sales: 1-614-588-8538 (Ext-101) Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc

Cancer Testing Equipment Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

Table of Contents 1. Cancer Testing/Screening Market - Overview 1.1. Definitions and Scope 2. Cancer Testing/Screening Market - Executive summary 2.1. Market Revenue, Market Size and Key Trends by Company 2.2. Key Trends by type of Application 2.3. Key Trends segmented by Geography 3. Cancer Testing/Screening Market 3.1. Comparative analysis 3.1.1. Product Benchmarking - Top 10 companies 3.1.2. Top 5 Financials Analysis 3.1.3. Market Value split by Top 10 companies 3.1.4. Patent Analysis - Top 10 companies 3.1.5. Pricing Analysis 4. Cancer Testing/Screening Market – Startup companies Scenario 4.1. Top 10 startup company Analysis by 4.1.1. Investment 4.1.2. Revenue 4.1.3. Market Shares 4.1.4. Market Size and Application Analysis 4.1.5. Venture Capital and Funding Scenario 5. Cancer Testing/Screening Market – Industry Market Entry Scenario 5.1. Regulatory Framework Overview 5.2. New Business and Ease of Doing business index 5.3. Case studies of successful ventures 5.4. Customer Analysis – Top 10 companies 6. Cancer Testing/Screening Market Forces 6.1. Drivers 6.2. Constraints 6.3. Challenges 6.4. Porters five force model 6.4.1. Bargaining power of suppliers 6.4.2. Bargaining powers of customers 6.4.3. Threat of new entrants 6.4.4. Rivalry among existing players 6.4.5. Threat of substitutes 7. Cancer Testing/Screening Market -Strategic analysis 7.1. Value chain analysis 7.2. Opportunities analysis 7.3. Product life cycle 7.4. Suppliers and distributors Market Share 8. Cancer Testing/Screening Market – By Type (Market Size -$Million / $Billion) 8.1. Market Size and Market Share Analysis 8.2. Application Revenue and Trend Research 8.3. Product Segment Analysis 8.3.1. Introduction 8.3.2. Lung Cancer 8.3.3. Blood Cancer 8.3.4. Bone Cancer 8.3.5. Gall Bladder Cancer

Cancer Testing Equipment Market

8.3.6. Testicular Cancer 8.3.7. Thyroid Cancer 8.3.8. Kidney Cancer 8.3.9. Liver Cancer 8.3.10. Pancreatic Cancer 8.3.11. Brain Cancer 8.3.12. Abdominal Cancer 8.3.13. Eye Cancer 8.3.14. Mouth Cancer 8.3.15. Breast Cancer 8.3.16. Cervix Cancer 8.3.17. Ovarian Cancer 8.3.18. Others 9. Cancer Testing/Screening Market – By Technique (Market Size -$Million / $Billion) 9.1. Introduction 9.2. Imaging Techniques 9.2.1. CT scan 9.2.2. MRI 9.2.3. X-ray 9.2.4. Nuclear 9.2.5. Ultrasound 9.2.6. Mammography 9.2.7. Others 9.3. Endoscopy procedure 9.3.1. Colonoscopy 9.3.2. Sigmoidoscopy 9.3.3. Others 9.4. Biopsy and cytology tests 9.4.1. Needle biopsy 9.4.2. CT-guided biopsy 9.4.3. Ultrasound-guided biopsy 9.4.4. Bone biopsy 9.4.5.Bone marrow biopsy 9.4.6.Liver biopsy 9.4.7.Kidney biopsy 9.4.8. Aspiration biopsy 9.4.9. Prostate biopsy 9.4.10 Skin biopsy 9.4.11 Surgical biopsy 9.4.12 Others 9.5. Genomic and Molecular tests 9.5.1. Next Generation Sequencing (NGS) 9.5.2. RT- PCR 9.5.3. icroarray techniques 9.5.4. Biomarker testing 9.5.5. Others 10. Cancer Testing/Screening Market – By Stage (Market Size -$Million / $Billion) 10.1. TNM Stages 10.2. Stages 0,1,2,3,4 10.3. Prognostic Factors 10.4. Other Staging Systems 11. Cancer Testing/Screening Market – By Gender (Market Size -$Million / $Billion) 11.1. Men 11.1.1. New Born 11.1.2. Infant 11.1.3. Child 11.1.4. Adolescent 11.1.5. Adults

Cancer Testing Equipment Market

11.1.6. Seniors 11.2. Women 11.2.1. New Born 11.2.2. Infant 11.2.3. Child 11.2.4. Adolescent 11.2.5. Adults 11.2.6. Seniors 12. Cancer Testing/Screening - By Geography (Market Size -$Million / $Billion) 12.1. Cancer Testing/Screening Market - North America Segment Research 12.2. North America Market Research (Million / $Billion) 12.2.1. Segment type Size and Market Size Analysis 12.2.2. Revenue and Trends 12.2.3. Application Revenue and Trends by type of Application 12.2.4. Company Revenue and Product Analysis 12.2.5. North America Product type and Application Market Size 12.2.5.1. U.S. 12.2.5.2. Canada 12.2.5.3. Mexico 12.2.5.4. Rest of North America 12.3. Cancer Testing/Screening - South America Segment Research 12.4. South America Market Research (Market Size -$Million / $Billion) 12.4.1. Segment type Size and Market Size Analysis 12.4.2. Revenue and Trends 12.4.3. Application Revenue and Trends by type of Application 12.4.4. Company Revenue and Product Analysis 12.4.5. South America Product type and Application Market Size 12.4.5.1. Brazil 12.4.5.2. Venezuela 12.4.5.3. Argentina 12.4.5.4. Ecuador 12.4.5.5. Peru 12.4.5.6. Colombia 12.4.5.7. Costa Rica 12.4.5.8. Rest of South America 12.5. Cancer Testing/Screening - Europe Segment Research 12.6. Europe Market Research (Market Size -$Million / $Billion) 12.6.1. Segment type Size and Market Size Analysis 12.6.2. Revenue and Trends 12.6.3. Application Revenue and Trends by type of Application 12.6.4. Company Revenue and Product Analysis 12.6.5. Europe Segment Product type and Application Market Size 12.6.5.1. U.K 12.6.5.2. Germany 12.6.5.3. Italy 12.6.5.4. France 12.6.5.5. Netherlands 12.6.5.6. Belgium 12.6.5.7. Spain 12.6.5.8. Denmark 12.6.5.9. Rest of Europe 12.7. Cancer Testing/Screening â&#x20AC;&#x201C; APAC Segment Research 12.8. APAC Market Research (Market Size -$Million / $Billion) 12.8.1. Segment type Size and Market Size Analysis 12.8.2. Revenue and Trends 12.8.3. Application Revenue and Trends by type of Application 12.8.4. Company Revenue and Product Analysis 12.8.5. APAC Segment â&#x20AC;&#x201C; Product type and Application Market Size

Cancer Testing Equipment Market

12.8.5.1. China 12.8.5.2. Australia 12.8.5.3. Japan 12.8.5.4. South Korea 12.8.5.5. India 12.8.5.6. Taiwan 12.8.5.7. Malaysia 13. Cancer Testing/Screening Market - Entropy 13.1. New product launches 13.2. M&A's, collaborations, JVs and partnerships 14. Cancer Testing/Screening Market – Industry / Segment Competition landscape 14.1. Market Share Analysis 14.1.1. Market Share by Country- Top companies 14.1.2. Market Share by Region- Top 10 companies 14.1.3. Market Share by type of Application – Top 10 companies 14.1.4. Market Share by type of Product / Product category- Top 10 companies 14.1.5. Market Share at global level- Top 10 companies 14.1.6. Best Practises for companies 15. Cancer Testing/Screening Market – Key Company List by Country 16. Cancer Testing/Screening Market Company Analysis 16.1. Market Share, Company Revenue, Products, M&A, Developments 16.2. Dias Orin S.P.A 16.3. Epigenetics Ag 16.4. Techlab 16.5. Positive Bioscience 16.6. Genextropy Inc. 16.7. M Genomics Ltd 16.8. 20/20 GeneSystems, Inc. 16.9. AB SCIEX 16.10. Abbott Laboratories 16.11. Abcodia Ltd. 16.12. Company 11 16.13. Company 12 16.14. Company 13 and more "*Financials would be provided on a best efforts basis for private companies" 17. Cancer Testing/Screening Market -Appendix 17.1. Abbreviations 17.2. Sources 18. Cancer Testing/Screening Market -Methodology 18.1. Research Methodology 18.1.1. Company Expert Interviews 18.1.2. Industry Databases 18.1.3. Associations 18.1.4. Company News 18.1.5. Company Annual Reports 18.1.6. Application Trends 18.1.7. New Products and Product database 18.1.8. Company Transcripts 18.1.9. R&D Trends 18.1.10. Key Opinion Leaders Interviews 18.1.11. Supply and Demand Trends

Cancer Testing Equipment Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

IndustryARC Solutions We cater to the pain points of our clients by providing the following solutions, which are targeted and address key issues specifically. Each of the business verticals is helpful to a client at various stages of their operational, managerial and strategic level plans. Syndicate Reports and Consulting (SRC) 1. Provide high quality analytical syndicated reports with key market insights, strategies and market forecasts for a specific industry or vertical of the clients. Constant tracking of industries and relations with experts helps us to predict and publish reports before our competitors as well as meet client needs proactively. Market Research and Data Analytics (MRDA) 2. Provide pure play data analytics services for ad-hoc and long-term engagement projects of clients with market research layered into the analysis. We are the only global company to offer this combination one-stop service to clients. Redundancies generally seen by procuring data, analytics services from multiple vendors is overcome by our solution. Competitive Landscape Analysis (CLA) 3. Provide company financial analysis, market share analysis, competitive landscape insights and market movements to clients. This is one of the most important pain point and key request from majority of our clients, for which we use our proprietary methodologies to provide accurate CLA data. Accelerated Business Development (ABD) 4. Connect clients with their customers on a global scale by acting as an outsourced sales team on behalf of the client. This is a unique tri-party engagement model to benefit the client and their customer, and acts as a business development scale up at an international level. Market Intel Reports (MIR) 5. Provide one-stop venue with a searchable syndicate reports database from global companies available to clients. This augments our offerings exponentially and also assists in studying global client needs at an in-depth level.

Cancer Testing Equipment Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

About IndustryARC IndustryARC strategy studies primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business. We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals.

We Work for You For IndustryARC, we value every customer equally. We only stay ready to help each client in the best way possible with a unique 24x365 support plan. We suggest looking at the following benefits of relying on Professional Business Consulting and Custom Market Research Services to realize the unique strategic gains on offer: 1. 2. 3. 4. 5. 6. 7.

Strengthen and improve organizational performance Strategic planning and analysing Adoption of newer and cost-effective technologies Become environmentally sustainable and profitable Improve their training and certification procedures. Planning for business automation. Project facilitation and management.

Cancer Testing Equipment Market

010